Teva Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TEVA and other ETFs, options, and stocks.

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. 

CEO
Richard Francis
CEORichard Francis
Employees
33,346
Employees33,346
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
1901
Founded1901
Employees
33,346
Employees33,346

TEVA Key Statistics

Market cap
44.16B
Market cap44.16B
Price-Earnings ratio
23.10
Price-Earnings ratio23.10
Dividend yield
Dividend yield
Average volume
6.26M
Average volume6.26M
High today
$35.85
High today$35.85
Low today
$34.30
Low today$34.30
Open price
$34.34
Open price$34.34
Volume
8.77M
Volume8.77M
52 Week high
$37.35
52 Week high$37.35
52 Week low
$14.99
52 Week low$14.99

TEVA News

Simply Wall St 4h
Teva Stock Faces Earnings Shock Despite Strong Brand Growth - simplywall.st

...

Teva Stock Faces Earnings Shock Despite Strong Brand Growth - simplywall.st
Simply Wall St 1d
Teva Pharmaceutical Industries Raises Revenue Guidance, Is The 15% Undervaluation Still There?

Teva Pharmaceutical Industries (NYSE:TEVA) stock is reacting to a mixed update after the company raised its 2026 revenue guidance while reporting a quarterly ne...

Teva Pharmaceutical Industries Raises Revenue Guidance, Is The 15% Undervaluation Still There?
Nasdaq 2d
Teva Pharmaceutical Industries Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - Teva Pharmaceutical Industries (TEVA) will host a conference call at 8:00 AM ET on July 29, 2026, to discuss Q2 26 earnings results. To access the...

Teva Pharmaceutical Industries Q2 26 Earnings Conference Call At 8:00 AM ET

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

More TEVA News

Barron's 2d
Teva Stock Is Rebounding. Its Drug Pipeline Holds the Key to Growth.

Biotech and Pharma Earnings Preview Teva Stock Is Rebounding. Its Drug Pipeline Holds the Key to Growth. In this article TEVA Teva Pharmaceutical Industries wil...

Teva Stock Is Rebounding. Its Drug Pipeline Holds the Key to Growth.
Simply Wall St 3d
Should Teva’s Branded-Drug Pivot and Duvakitug Bet Reshape How TEVA Investors View Earnings Power?

In recent months, Teva Pharmaceutical Industries has accelerated its shift from generics to branded medicines, while absorbing near-term earnings dilution from...

Should Teva’s Branded-Drug Pivot and Duvakitug Bet Reshape How TEVA Investors View Earnings Power?
Simply Wall St 6d
Does Teva Pharmaceutical Industries Still Look Undervalued After A 260% Run?

Teva Pharmaceutical Industries has delivered a very large 259.9% return over the past three years, yet the current valuation picture is more balanced. Recent sh...

Does Teva Pharmaceutical Industries Still Look Undervalued After A 260% Run?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.